Ginkgo Bioworks Forum: Community User: NILUIS

Die Bewertung kann hier locker noch auf 4$ Fallen...

Hä was habt ihr bitte für Vorstellungen? Das Unternehmen ist einfach 15Mrd nur wegen HYPE! Bitte kommt zurück in die Realität...Danke!

Das es hier nochmal unter 7$ geht, hätte ich nicht gedacht. Selbst die großen sind bei über 10$ rein. Geduld ist gefragt. Bin jetzt auch kräftig im minus. Abwarten

Was ist denn hier los? 😰

Benjamin Franklin Institute of Technology, Ginkgo Bioworks to Launch Biotechnology Manufacturing Associates Degree https://www.prnewswire.com/news-releases/benjamin-franklin-institute-of-technology-ginkgo-bioworks-to-launch-biotechnology-manufacturing-associates-degree-301447853.html Initiative supported through a $100,000 grant from Kargman Family Foundation

https://www.businesswire.com/news/home/20211213005158/en/Eurofins%E2%80%99-Clinical-Enterprise-Launches-New-Partnership-with-Ginkgo-Bioworks-to-Support-Federally-Funded-COVID-19-PCR-Testing-Program

Concentric by Ginkgo Confirms Detection of Omicron Variant through COVID-19 Air Travel Biosecurity Collaboration with CDC and XpresCheck https://www.prnewswire.com/news-releases/concentric-by-ginkgo-confirms-detection-of-omicron-variant-through-covid-19-air-travel-biosecurity-collaboration-with-cdc-and-xprescheck-301438589.html ... This joint biosecurity effort leverages Concentric's large scale group testing infrastructure and XpresCheck's in-airport testing platform to monitor travelers for COVID-19 and its variants. The goal of this program is to create a system that detects and provides information on the virus. Currently, the program is in four large airports: JFK International Airport (JFK), Newark Liberty International Airport (EWR), San Francisco International Airport (SFO), and Hartsfield-Jackson Atlanta International Airport (ATL), which was added during a recent expansion of the already-operational program.  ...

So habe erst mal eine kleine Tranche gekauft, aber die Bewertung müsste mindestens 40% runter gehen.

XpresSpa Group and Ginkgo Bioworks Collaboration with the Centers for Disease Control and Prevention (CDC) COVID-19 Biosurveillance Program Expands to Include Detection of the New Omicron Variant https://www.globenewswire.com/news-release/2021/11/30/2343189/0/en/XpresSpa-Group-and-Ginkgo-Bioworks-Collaboration-with-the-Centers-for-Disease-Control-and-Prevention-CDC-COVID-19-Biosurveillance-Program-Expands-to-Include-Detection-of-the-New-Om.html The current COVID-19 variant surveillance program is offered at John F. Kennedy International Airport, Newark-Liberty International Airport, San Francisco International Airport, and is now expanding to Hartsfield-Jackson Atlanta International Airport

Die Bewertungen ist einfach maßlos übertrieben. Denke wir sehen Kurse von 7

https://www.prnewswire.com/news-releases/mrna-victoria-and-ginkgo-bioworks-announce-partnership-to-grow-the-bioeconomy--international-biosecurity-capabilities-301426441.html

Ginkgo Bioworks Reports Third Quarter 2021 Results https://www.prnewswire.com/news-releases/ginkgo-bioworks-reports-third-quarter-2021-results-301423954.html Foundry revenue of $34.7 million in Q3 and $78.8 million year-to-date, with strong growth driven by both continued execution and realization of downstream value share 8  products have been manufactured at scale from Ginkgo programs; number has more than doubled in year-to-date 2021 Biosecurity revenue of $42.9 million in Q3 and $86.5 million year-to-date has already exceeded full year outlook

Ginkgo Bioworks Launches Cell Development Kit Service for Standardized, Low-Cost Entry to its Cell Programming Platform https://www.prnewswire.com/news-releases/ginkgo-bioworks-launches-cell-development-kit-service-for-standardized-low-cost-entry-to-its-cell-programming-platform-301421988.html Streamlined toolkit for cell programming aims to provide developers with the platform, tools and expertise needed to launch protein production projects Ginkgo will be hosting an informational virtual event, Grow with Ginkgo: You're a Cell Developer, for prospective cell developers on Thursday, Nov. 11 from 10 a.m.-12 p.m. ET.

Hier spielt die Phantasie der Investoren eine große Rolle, schon seit der ersten Finanzierungsrunde mit Wagniskapitalgebern. Ich bleibe definitiv long, aber wenn es zu heiß gekocht wird, werde ich vorsichtig.

Hast auf jeden Fall recht und Zukunftschancen sehe ich hier definitiv. Ich 'arbeite' bei solchen Werten sowieso großteils mit Rücksetzern und Chancen. Bin damit bisher meist ganz gut gefahren.

Ja aber selbst crispr Therapeutics ist gerade mal 6 Mrd wert, obwohl die Technologie 100% Zukunft hat. (siehe das Video von Kurz gesagt auf Youtube). Und Gingko soll dann einfach 18Mrd wert sein? Sry, der Kurs wird sich hier noch stark korrigieren